Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Surgery Partners (SGRY) Other Operating Expenses (2016 - 2025)

Surgery Partners' Other Operating Expenses history spans 11 years, with the latest figure at -$5.1 million for Q3 2025.

  • For Q3 2025, Other Operating Expenses fell 920.0% year-over-year to -$5.1 million; the TTM value through Dec 2025 reached -$7.3 million, down 1012.5%, while the annual FY2025 figure was -$7.3 million, 1012.5% down from the prior year.
  • Other Operating Expenses for Q3 2025 was -$5.1 million at Surgery Partners, down from -$2.2 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $32.8 million in Q1 2022 and bottomed at -$5.1 million in Q3 2025.
  • The 4-year median for Other Operating Expenses is -$2.2 million (2025), against an average of $1.1 million.
  • The largest annual shift saw Other Operating Expenses surged 160.0% in 2024 before it crashed 920.0% in 2025.
  • A 4-year view of Other Operating Expenses shows it stood at -$3.5 million in 2022, then rose by 28.57% to -$2.5 million in 2023, then surged by 80.0% to -$500000.0 in 2024, then plummeted by 920.0% to -$5.1 million in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Other Operating Expenses are -$5.1 million (Q3 2025), -$2.2 million (Q1 2025), and -$500000.0 (Q3 2024).